York Bridge Wealth Partners, LLC Ligand Pharmaceuticals Inc Transaction History

York Bridge Wealth Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$86.25 - $120.16 $7,072 - $9,853	-82 Closed	0 $0
Q2 2019 Jul 18, 2019	SELL	$107.38 - $129.34 $1,503 - $1,810	-14 Reduced 14.58%	82 $9,000
Q1 2019 May 09, 2019	SELL	$105.93 - $142.47 $2,966 - $3,989	-28 Reduced 22.58%	96 $12,000
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $4,012 - $5,215	-19 Reduced 13.29%	124 $34,000
Q2 2018 Aug 10, 2018	SELL	$150.77 - $207.98 $6,784 - $9,359	-45 Reduced 23.94%	143 $30,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $3,049 - $4,017	22 Added 13.25%	188 $31,000
Q4 2017 Feb 12, 2018	SELL	$128.36 - $147.04 $256 - $294	-2 Reduced 1.19%	166 $25,000
Q3 2017 Oct 27, 2017	BUY	$120.91 - $137.94 $1,813 - $2,069	15 Added 9.8%	168 $23,000
Q2 2017 Aug 14, 2017	BUY	N/A	153	153 $18,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.